AVTX
#2431
Avalo Therapeutics, Inc. - Common Stock
18.9 5 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.02%
Variación mensual
+3.78%
Variación en los últimos 6 meses
+6.88%
Cambio anual
+112.92%
Cierres anteriores
19.3 4
Open
18.9 5
Mínimo
18.9 5
Máximo
18.9 5
Volumen
110
Financials
- Market Capitalization 1.02 B
- Employee 33
- Founded 2011
- CEO N/A
- Website www.avalotx.com
- Headquarter Delaware, United States
- FIGI BBG001QHW0Y8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.13
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2394 |  SVRA Savara, Inc. - Common Stock | 5.35 USD | -0.74% | -4.12% | -1.65% | +59.23% | 1.10 B USD | ||
| 2406 |  SLDB Solid Biosciences Inc. - Common Stock | 9.88 USD | +3.13% | +0.41% | +24.59% | +73.33% | 1.06 B USD | ||
| 2434 |  ABUS Arbutus Biopharma Corporation - Common Stock | 5.09 USD | +0.20% | -1.93% | +17.28% | +33.95% | 1.01 B USD | ||
| 2438 |  IMMX Immix Biopharma, Inc. - Common Stock | 14.01 USD | -0.14% | -3.04% | +69.41% | +536.82% | 1.00 B USD |